Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akso Health (AHG) Total Current Liabilities (2018 - 2025)

Akso Health (AHG) has disclosed Total Current Liabilities for 7 consecutive years, with $3.6 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Total Current Liabilities fell 69.07% year-over-year to $3.6 million, compared with a TTM value of $3.6 million through Mar 2024, down 69.07%, and an annual FY2024 reading of $3.6 million, down 69.07% over the prior year.
  • Total Current Liabilities was $3.6 million for Q1 2024 at Akso Health, down from $11.6 million in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $50.5 million in Q1 2022 and bottomed at $3.6 million in Q1 2024.
  • Average Total Current Liabilities over 5 years is $18.5 million, with a median of $12.4 million recorded in 2020.
  • The sharpest move saw Total Current Liabilities skyrocketed 250.5% in 2022, then tumbled 77.0% in 2023.
  • Year by year, Total Current Liabilities stood at $12.4 million in 2020, then rose by 16.6% to $14.4 million in 2021, then surged by 250.5% to $50.5 million in 2022, then crashed by 77.0% to $11.6 million in 2023, then crashed by 69.07% to $3.6 million in 2024.
  • Business Quant data shows Total Current Liabilities for AHG at $3.6 million in Q1 2024, $11.6 million in Q1 2023, and $50.5 million in Q1 2022.